Short answer: cranberry has real evidence at a specific dose, one probiotic species has one good trial in a different delivery form, and the rest runs on tradition and mechanism, not outcomes. The dose and the strain are everything — which is exactly what proprietary blends hide.

Bladder supplements for women lean on four ingredients: cranberry extract, uva-ursi (bearberry), berberine, and Lactobacillus probiotics. Marketing sells them as interchangeable “bladder support.” The literature does not. Here is each one against what has actually been published — the same evidence we apply in our FemiCore analysis, and the supporting act to the muscle-and-habit work in our bladder control guide.

Cranberry: the one with real evidence — at the right dose

Cranberry’s active fraction, A-type proanthocyanidins (PACs), interferes with E. coli adhesion to the urinary tract lining. That mechanism has outcome data behind it: the 2023 Cochrane review of 50 trials concluded, with moderate-certainty evidence, that cranberry products reduce the risk of symptomatic, culture-verified urinary tract infections in women with recurrent UTIs (why infections start repeating after 40 in the first place is its own story — our recurrent UTIs guide covers the estrogen-microbiome mechanism) — while finding no support for benefit in elderly institutionalized adults or people with bladder-emptying problems.

The dose is the catch. The FDA’s 2020 qualified health claim applies to supplements delivering at least 500 mg of cranberry fruit powder per day, and trials that measured PACs typically used around 36 mg of PACs daily. A product that discloses its cranberry dose and PAC content can be checked against those numbers. A product that folds cranberry into a multi-ingredient blend cannot — and that distinction does more work than any ingredient list.

Lactobacillus probiotics: strain-specific, and mostly studied vaginally

The idea is sound: the vaginal and urinary microbiomes of women with recurrent infections tend to be depleted of Lactobacillus, and recolonizing it should crowd out uropathogens. The best evidence belongs to one species in one delivery form: a randomized, placebo-controlled phase 2 trial of Lactobacillus crispatus CTV-05, given as a vaginal suppository after an acute infection, roughly halved recurrence in UTI-prone women.

Three honest limits. It was a phase 2 trial, not a definitive one. The product was intravaginal — evidence that an oral capsule delivers the same colonization is much weaker. And probiotic effects are strain-specific: a label listing L. crispatus, L. acidophilus, or L. gasseri without stating the strain and the CFU count cannot be mapped onto any published trial. CFU count matters most of all — probiotic doses in studies are measured in billions of organisms, and a blend disclosed only in milligrams leaves you unable to tell whether you are getting a study dose or a sprinkle.

Uva-ursi: tradition, a caution label, and a short clock

Bearberry leaf carries arbutin, which converts to an antimicrobial compound in alkaline urine. It has centuries of traditional use and a place in European herbal monographs — for short-term use in uncomplicated lower urinary tract complaints, typically capped at about a week, with advice against repeated courses, use in pregnancy, and use in kidney disease. That short-term framing is the point: uva-ursi is positioned in the literature as an acute-episode herb, not a daily maintenance ingredient. A supplement that includes it in a daily-use formula is using it outside the pattern the tradition and the monographs describe.

Berberine: real compound, wrong department

Berberine is genuinely interesting — in metabolic research, where trials use 500 mg two to three times daily for blood sugar and lipids. For urinary or bladder outcomes in women, controlled trials are essentially absent. Its presence in a bladder formula rests on general antimicrobial mechanism, not on outcome data. And the metabolic doses that made berberine’s reputation are more than the entire herbal blend of most bladder products.

How to read any bladder supplement label

  1. Cranberry: demand the number. 500 mg of fruit powder or ~36 mg PACs daily is the evidence-anchored range. “Cranberry extract” inside a blend is unverifiable.
  2. Probiotics: strain codes and CFUs, or it does not count. Species names alone cannot be matched to trials.
  3. Blends hide arithmetic. A 350 mg blend of four herbs cannot contain 500 mg of anything — the math closes the question before the marketing opens it.
  4. Daily formulas with acute-use herbs (uva-ursi) signal formulation by theme, not by literature.

That checklist is the entire method behind our FemiCore label analysis — the numbers above are the yardstick, the label is the evidence, and the gap between them is the review.